Get the latest Science News and Discoveries
None
Get the Android app
Read more on:
safety
New method
critical situations
Related news:
Novel dual-target IL-17A/F monoclonal antibody XKH004 shows 52-week efficacy and safety in active ankylosing spondylitis in phase 3 trial
Extended-interval tarlatamab dosing shows consistent activity and safety in previously treated small cell lung cancer